|
Status |
Public on Sep 30, 2023 |
Title |
PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors [RNA-seq] |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Fusion-positive rhabdomyosarcoma (FP-RMS) driven by the expression of the PAX3-FOXO1 (P3F) fusion oncoprotein is an aggressive subtype of pediatric rhabdomyosarcoma. FP-RMS histologically resembles developing muscle yet occurs throughout the body in areas devoid of skeletal muscle highlighting that FP-RMS is not derived from an exclusively myogenic cell of origin. Here we demonstrate that P3F reprograms mouse and human endothelial progenitors to FP-RMS. We show that P3F expression in aP2-Cre expressing cells reprograms endothelial progenitors to functional myogenic stem cells capable of regenerating injured muscle fibers. Further, we describe a FP-RMS mouse model driven by P3F expression and Cdkn2a loss in endothelial cells. Additionally, we show that P3F expression in TP53-null human iPSCs blocks endothelial-directed differentiation and guides cells to become myogenic cells that form FP-RMS tumors in immunocompromised mice. Together these findings demonstrate that FP-RMS can originate from aberrant development of non-myogenic cells driven by P3F.
|
|
|
Overall design |
RNA was harvested at Day 0 and Day 15 of a 14 day Endothelial differentiation protcol. Cells were transduced with P3F or left untreated at Day 5 of the protocol so that we could deteremine the effect of enforced P3F expression on endothelial differentiation
|
|
|
Contributor(s) |
Searcy MB, Jin H, Gadek K, Stevens B, Larsen R, Hatley ME |
Citation(s) |
37968277 |
|
Submission date |
Aug 24, 2023 |
Last update date |
Jan 03, 2024 |
Contact name |
Hongjian Jin |
E-mail(s) |
hongjian.jin@STJUDE.ORG
|
Organization name |
St Jude Children's Research Hospital
|
Department |
Center for Applied Bioinformatics
|
Street address |
262 Danny Thomas Place
|
City |
Memphis |
State/province |
TN |
ZIP/Postal code |
38015 |
Country |
USA |
|
|
Platforms (1) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (3) |
|
This SubSeries is part of SuperSeries: |
GSE218274 |
PAX3-FOXO1 expression in endothelial progenitors dictates myogenic reprogramming and rhabdomyosarcoma identity |
|
Relations |
BioProject |
PRJNA1009038 |